e8vk
Table of Contents



SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of earliest event reported: July 30, 2003


Select Medical Corporation


(Exact name of registrant as specified in charter)
         
Delaware   000-32499   23-2872718

 
 
(State of Incorporation)   (Commission File Number)   (I.R.S. Employer
Identification No.)

4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055


(Address of Principal Executive Offices) (Zip Code)

(717) 972-1100


(Registrant’s telephone number, including area code)



 


TABLE OF CONTENTS

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
Item 9. Regulation FD Disclosure.
SIGNATURE
EXHIBIT INDEX
SELECT MEDICAL CORPORATION INVESTOR PRESENTATION


Table of Contents

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

     (c)  Exhibits

     
99.1   Select Medical Corporation Investor Presentation dated July 2003.

Item 9. Regulation FD Disclosure.

     Attached as exhibit 99.1 and furnished for purposes of Regulation FD is an Investor Presentation that may be given by Select Medical Corporation at events during July and August 2003.

 


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
    SELECT MEDICAL CORPORATION
         
Date: July 30, 2003   By:   /s/ Michael E. Tarvin
       
        Michael E. Tarvin
        Senior Vice President, General Counsel and Secretary

 


Table of Contents

EXHIBIT INDEX

     
Exhibit No.   Description

 
99.1   Select Medical Corporation Investor Presentation dated July 2003.